Your session is about to expire
← Back to Search
Intranasal Insulin for Post-Surgery Delirium
Study Summary
This trial is studying whether intranasal insulin during and after heart surgery can help improve cognitive function postoperatively in patients experiencing POCD or POD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for open heart surgery with a heart-lung machine.I am allergic to insulin.Your native language is not English or French.I have vision or hearing problems that could affect taking tests.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Intranasal Normal Saline
- Group 2: Intranasal Insulin 40 IU
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Frequently Asked Questions
Is this trial actively enrolling participants at the present time?
"At the present moment, this trial is not recruiting new participants. It was first announced on November 1st 2021 and last edited 13 days prior. For those in search of alternative trials, 473 related to delirium are actively seeking applicants while 72 studies concerning Regular Insulin Human 100 UNT/ML are currently enrolling patients."
Could you elucidate what other research initiatives have been undertaken with Regular Insulin, Human 100 UNT/ML?
"Presently, there are 72 studies ongoing for Regular Insulin, Human 100 UNT/ML with 13 trials in its final phase. A large number of the experiments concerning this medication are based out of Sao Luis, MA yet 248 locations globally have clinical trial programs involving Regular Insulin, Human 100 UNT/ML."
What is the scope of enrollment for this clinical trial?
"Participants are not being sought out at this time for the clinical trial, which was initialy listed on November 1st 2021 and last modified October 13th 2021. However, if one is looking to join a study there are 473 trials recruiting patients with delirium and 72 trials enrolling those requiring Regular Insulin Human 100 UNT/ML."
What is the desired outcome of this research?
"This clinical trial, with a 12 month evaluation window, seeks to assess patient's cognitive function using the Confusion Assessment method for the ICU. Secondary objectives include an Information Processing Speed test (Symbol Digit Modalities Test), Visuospatial Function tasks (Clock Drawing Test; scores range from 1-10), and Executive Function exercises (Stroop Test)."
Share this study with friends
Copy Link
Messenger